Table 1 Regulators of CLK proteins
From: Cdc2-like kinases: structure, biological function and therapeutic targets for diseases
Name | Interaction | Subtypes | Biological function | Ref. |
|---|---|---|---|---|
Downstream regulators | ||||
SRSF1 | Downstream of CLK1 | Hyperphosphorylation | Hyperphosphorylation of SRSF1 by CLK1 furtherly facilitated the binding of SRSF1 to Ron ESE | |
Downstream of CLK2 | Phosphorylation | Downregulated CLK2 expression decreased the phosphorylation status of SRSF1to inhibit its splicing function | ||
Downstream of CLK3 | Splicing modulation | CLK3 strongly affected HMGA2 isoforms switching in an SRSF1-dependent manner | ||
SRSF2 | Downstream of CLK1 | Splicing modulation | CLK1 inhibition decreased SRSF2 expression and downregulated CLK1-dependent SRSF2 splicing activity in gastric cancer cells | |
SRSF4 and SRSF6 | Downstream of CLK1 | Phosphorylation | CLK1(Clk/Sty) phosphorylated SRSF4 and SRSF6 during insulin stimulation resulting in exon 17 inclusion and elevated expression of PKCβII | |
SRSF5 | Downstream of CLK1 | Phosphorylation at Ser250 | CLK1 promoted alternative splicing of METTL14 and Cyclin L2 in pancreatic cancer | |
SRSF10 | Downstream of CLK1 | Phosphorylation at Ser129, 131 and 133 | CLKs modulated the tumorigenic activity of SRSF10 in human colorectal cancer cells | |
SPF45 | Downstream of CLK1 | Phosphorylation at eight serine residues | CLK1 enhanced SPF45-induced Fas mRNA exon 6 exclusion Inhibition of CLK1 promoted SPF45 degradation via proteasome-dependent proteolysis | |
U1–70K | Downstream of CLK1 | Phosphorylation at Ser226 | Facilitated U1–70K released from subnuclear granules and subsequent interaction with U1 snRNP and SRSF1 | |
RBFOX2 | Downstream of CLK2 | Splicing modulation | Mediated mesenchymal-type ENAH splicing at exon 11a | |
PTP-1B | Downstream of CLK1/2 | Phosphorylation at Ser50 | Activated PTP-1B and modulated the enzymatic activity | |
B56β | Downstream of CLK2 | Phosphorylation | Phosphorylation of B56β by CLK2 leads to AKT dephosphorylation at Ser473 and Thr308 sites | |
PGC-1α | Downstream of CLK2 | Phosphorylation at 11 serine residues on SR domain | Disrupted the PGC-1α–MED1 interaction and reduced MED1 recruitment to PPARα/PGC-1α promoter resulting in decreased fatty acid oxidation CLK2 phosphorylated the SR domain of PGC-1α to repress PGC-1α transcriptional activity on gluconeogenic genes in hepatic gluconeogenesis | |
USP13 | Downstream of CLK3 | Phosphorylation at Y708 | Promoted USP13 binding with c-Myc, resulting in the activation of purine metabolic gene transcription in CCA | |
NEXN | Downstream of CLK4 | Phosphorylation at Ser437 | CLK4 phosphorylated NEXN at Ser437 to participate in cardiac function regulation | |
MITF | Downstream of CLK4 | Phosphorylation at Tyr360 | CLK4 phosphorylated MITF at Tyr360 to promote the degradation of MITF | |
Aurora B | Downstream of CLKs | Phosphorylation at Ser331 | Activated Aurora B during late cytokinesis in normally segregating cells | |
Upstream regulators | ||||
AKT | Upstream of CLK1 | Phosphorylation CLK1 at SR domain (Ser36, Thr122 and Ser139) | AKT phosphorylated the SR domain of CLK1 | |
Upstream of CLK2 | Phosphorylation CLK2 at Ser34, Thr127 and Thr343 | AKT bond and phosphorylated CLK2 at Ser 34 and Thr 127 in response to ionizing radiation AKT phosphorylated CLK2 at Thr343 in response to insulin stimulation in hepatic gluconeogenesis | ||
Insulin stimuli | Upstream of CLK2 | Phosphorylation CLK2 at Ser342 and Thr343 | CLK2 kinase activity was induced by insulin at Ser342/Thr343 in hepatic gluconeogenesis | |
miR-573 | Upstream of CLK2 | Regulator | miR-573 bond directly with CLK2 and significantly inhibited the expression of CLK2 | |
14–3–3τ | Upstream of CLK2 | Regulator | 14–3–3τ bond with CLK2 to prevent the proteasomal degradation of CLK2 and increase protein stabilization in glioma stem cells | |
c-Myc | Upstream of CLK3 | Transcriptional activator | c-Myc overexpression enhanced CLK3 expression | |
miR-144 | Upstream of CLK3 | Regulator | miR-144 post-transcriptionally regulated CLK3 to suppress Wnt/β-catenin signaling in hepatocellular carcinoma | |
MITF | Upstream of CLK4 | Regulator (Feedback loop) | MITF bond to the E-boxes in the CLK4 promoter to reduce CLK4 transcript expression in ESCC | |